Georgia Capital 3Q23 & 9M23 Performance Overview
AGGREGATED LEVERAGE OVERVIEW ACROSS OUR LARGE
AND INVESTMENT STAGE PORTFOLIO COMPANIES
GEORGIA
CAPITAL
ADJUSTED¹ NET DEBT/EBITDA
DEVELOPMENT OVERVIEW
LTM EBITDA up 13.1% as at Sep-23 from Dec-19.
3.1x
3.2x
3.1x
2.8x
2.6x
2.6x
2.6x
2.5x
2.6x
2.7x
2.8x
2.4x
89
124
131
92
92
93
80
184
186
197
224
235 472 238 499 223 535 218460 206 435 203 447 209 584 208 631
Dec-19 Jun-20
Dec-20
Jun-21
Dec-21
Mar-22 Jun-22
Sep-222 Dec-22 Mar-23 Jun-23 Sep-233
LTM EBITDA
Adjusted Net debt¹
Adjusted Net debt/EBITDA
Minority buyout agreement at Retail (Pharmacy)
Georgia Capital PLC | General note: Figures for Hospitals, Retail (Pharmacy), Clinics and Diagnostics are given excluding IFRS 16 effects. 1. Adjusted for capital commitments. 2. Renewable energy business net debt, excluding US$ 10
million quasi equity. 3. LTM EBITDA excludes the gain of GEL 2.9 million from the sale of one of the polyclinics buildings in 3Q23. The net debt includes the receivable of US$ 6.2 million incurred from the sales transaction.
20
20View entire presentation